Latest news
Categories
News archive
Penser Access inleder bevakning av Nanologica
18 December, 2020
Penser Access inleder bevakning av Nanologica genom Klas Palins försorg. Idag släpptes en initierande uppdragsanalys som finns att läsa via Penser Access. Länk till analysen
DDL 2020 – Drug Delivery to the Lungs Conference
9 December, 2020
Nanologica is attending the Drug Delivery to the Lungs conference (DDL) during Dec 9-11. The DDL is the premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery. The focus is on providing a forum to present t recent developments in the field of inhalation therapy. Representing Nanologica is Prof. Adam Feiler, CTO.
Publication on Empty Particles for the Treatment of ALS
26 November, 2020
The publication “Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS” has been published in Nature Research Scientific Reports, Nov 26, 2020. The publication relates to Nanologica’s patent application “Porous particles for use in treatment, prevention and/or postponement of degeneration of neurons and glia” that became public on Oct. 15, and demonstrates how empty porous silica particles has the potential of delaying the disease progression and extending